Cargando…
Integrated transcriptomics reveals master regulators of lung adenocarcinoma and novel repositioning of drug candidates
BACKGROUND: Lung adenocarcinoma is the major cause of cancer‐related deaths in the world. Given this, the importance of research on its pathophysiology and therapy remains a key health issue. To assist in this endeavor, recent oncology studies are adopting Systems Biology approaches and bioinformati...
Autores principales: | De Bastiani, Marco Antônio, Klamt, Fábio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825976/ https://www.ncbi.nlm.nih.gov/pubmed/31503425 http://dx.doi.org/10.1002/cam4.2493 |
Ejemplares similares
-
Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning
por: De Bastiani, Marco A., et al.
Publicado: (2018) -
Alzheimer’s disease master regulators analysis: search for potential molecular targets and drug repositioning candidates
por: Vargas, D. M., et al.
Publicado: (2018) -
A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates
por: Chapola, Henrique, et al.
Publicado: (2023) -
A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer
por: Yang, Chen, et al.
Publicado: (2022) -
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction
por: Bornschein, Jan, et al.
Publicado: (2019)